Factors and outcomes associated with acute kidney injury in brain tumor resection patients: insights from a large US database (2010-2019)

脑肿瘤切除术患者急性肾损伤的相关因素和结果:来自美国大型数据库的启示(2010-2019)

阅读:2

Abstract

Acute kidney injury (AKI) is a major perioperative complication following brain tumor resection, yet multi-center studies on this topic remain scarce. This study aimed to determine the incidence, risk factors, and clinical outcomes associated with AKI in patients undergoing brain tumor resection, utilizing a nationally representative dataset. We analyzed brain tumor resection admissions from the United States' National Inpatient Sample database (2010-2019), identifying hospitalizations with and without AKI using International Classification of Diseases, Ninth Revision, Clinical Modification and International Classification of Diseases, Tenth Revision, Clinical Modification codes. Multivariable logistic regression analyses were performed to evaluate the associations between patient/hospital characteristics, comorbidities, complications and AKI. Among more than 40,000 brain tumor resection admissions, AKI occurred in 3.1% of hospitalizations, with prevalence rising from 1.8% in 2010 to 4.4% in 2019. AKI-associated admissions had higher costs (median $171,904 vs. $99,821, p < .001), longer hospital stays (median 11 vs. 5 days), increased mortality (8.3% vs. 1.2%, p < .001), higher dialysis requirement (1.1% vs. 0.01%, p < .001), and mechanical ventilation (12.1% vs. 3.0%, p < .001). Associated risk factors for AKI included: age ≥65 years, Black/Hispanic race, congestive heart failure, diabetes, fluid and electrolyte disorders, other neurological disorders, obesity, and chronic kidney disease excluding end-stage renal disease. Medical complications associated with increased AKI risk included septicemia, deep vein thrombosis, urinary tract infection, pneumonia, and cerebral edema. Female sex and elective admission were protective factors. Prompt identification of these risk factors is crucial for optimizing perioperative management and improving clinical outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。